GlobeNewswire by notified

DFDS launches new Initiative to Protect Sperm Whales in Southern Greece

Share

At DFDS, our awareness of how our ferry and logistics activities impact biodiversity is growing. We are taking essential steps to protect marine life in the Mediterranean around the Southern part of Greece, a critical habitat for endangered sperm whales.

Sofie Lindegaard, Head of Group Sustainability, explains, "Our responsibility to the marine life in the waters we operate is crucial. We want to ensure that our operations respect the different ecosystems."

"Working closely with NGOs is an invaluable way to get insights into important and sometimes unknown areas and constructive input on how to address it," Sofie adds.

Together with a coalition of NGOs, including IFAW, Ocean Care, Pelagos Cetacean Institute, and WWF Greece, DFDS has developed initiatives to reduce vessel-whale collisions in the Hellenic Trench in Southern Greece:

  • Route Adjustments: We have redefined our vessel routes to avoid high-risk areas known for frequent sperm whale sightings.
  • Slow Steaming: We have limited vessel speeds in these high-risk zones to minimize the potential of collisions.
  • Spotting and Reporting: We have initiated a policy encouraging all Masters to maintain vigilance, identify whales, and communicate sightings promptly to DFDS vessels and other ships in the vicinity.

Kemal Bozkurt, VP for Operations, Mediterranean, has been part of developing these changes and sheds light on the crew's response. "The crews have understood and supported the importance of these conservation efforts, which require heightened vigilance and the maintenance of reduced speeds in high-risk zones."

While the route adjustments and slow steaming have extended our trip durations, the impact has been minimal: "On average, we are seeing an increase of 15-30 min per leg, which allows us to prioritize the protection of animals without disrupting our schedules." 

The changes will not have a big impact on our customers; Kemal ensures: "Our customers' experiences remain a top priority. So while there may be slight adjustments to our schedules, most will not affect our customers. And if they do, we have made efforts to communicate the reasons behind these changes."

The changes apply to vessels calling Pendik, Trieste, Sete and Yalova.

About DFDS
DFDS provides ferry and transport services in and around Europe, generating annual revenues of around DKK 27bn.
We deliver high reliability to over 10,000 freight customers through ferry & port terminal services and transport & logistics solutions.
For millions of passengers, we provide safe overnight and short sea ferry services.
Our 12,000 employees are located on ferries, terminals, distribution centres, and offices across more than 20 countries. DFDS was founded in 1866, headquartered in Copenhagen, and listed on Nasdaq Copenhagen.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration3.10.2023 22:05:00 CEST | Press release

PHAXIAM Therapeutics and Vetophage Announce Strategic ResearchCollaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapy Combining expertise in the research of new phages and phage endolysins that could be applied to human health Exclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge (MA, US), October03, 2023 – 10:05pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) and Vetophage, a company specialized in phage therapy applied to animal health, announce the signature of a long-term strategic research partnership to combine their expertise in the research of new phages and phage-derived proteins (endolysins) in the fight against antimicrobial resistance. Vetophage is a Lyon-based biotechnology company founded in 2017. It develops new tools to detect pathogenic bacteria and alternative solutions to antibiotics based on phages an

Kvika banki hf.: TM Insurance to be sold or listed3.10.2023 21:05:43 CEST | Press release

Following a strategic review at Kvika banki hf. ("Kvika" or "the bank"), the board of directors of Kvika has decided to initiate a process for the sale or listing of its insurance subsidiary TM tryggingar hf. ("TM"). The decision is in line with the bank's vision, where emphasis is placed on simplifying the group's operations and strengthening Kvika's traditional banking activities, in accordance with the bank's goal to increase competition and simplify its customers' finances. Following the divestment of TM, Kvika's main operations will be focused on commercial- and investment banking, along with asset management. It is expected that Kvika's capital base will grow significantly following the divestment of TM, enabling the bank to pursue internal growth opportunities across Kvika's business segments. Increased capital will, among other things, enable the bank to strengthen its market position, in both retail and corporate lending, and increase the risk diversification of its loan book.

Policane® Natural Sweetener Found to Have Low Glycemic Index3.10.2023 20:06:38 CEST | Press release

OCALA, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Policane®, a natural sweetener made from sugar cane juice in a patented process, has been found to have a low glycemic index (GI) in a study by IFP Suisse SA. According to the study Policane® has a GI of 51.7+/- 3.66. The study also found that Policane® had a 42% lower GI than white sugar. In its conclusion, the study recommends for Policane® a low glycaemic index product classification under International Standard ISO26642. “We are excited to share the results of this study, providing that Policane® is a low-GI sweetener,” said Jorge Enrique Gonzalez, Manager and CEO at PoliCane Co., LLC. “Policane® retains the best parts of the sugar cane stripped away in refined sugar. Policane® is a natural and sustainable sweetener that the world needs.” Policane® is currently produced under license in Costa Rica and can be used in recipes for all sweetened food and beverages, including baked goods, coffee, tea, colas, sauces, ketchup and desserts. Fo

Nokia Corporation: Repurchase of own shares on 03.10.20233.10.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 3 October 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 03.10.2023 Espoo, Finland – On 3 October 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL344,5423.53CEUX39,5413.54AQEU1,3923.53TQEX14,5253.55Total400,0003.53 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023

Adevinta ASA – Procedures established in response to receipt of non-binding indicative proposal3.10.2023 19:30:00 CEST | Press release

Oslo, 3 October 2023 – Adevinta ASA (“Adevinta” or the “Company”) refers to the stock exchange announcement on 21 September 2023 regarding receipt of a non-binding indicative proposal (the “Proposal”) from a consortium led by Permira and Blackstone, with involvement of the Company’s two main shareholders, regarding a potential offer for all shares of the Company. In response to shareholder enquiries, the Company wants to communicate the procedures it is following in response to the Proposal. Immediately upon receipt of the Proposal, the Company’s board of directors established a special committee comprising the five independent directors on the Company’s board. The special committee is representing the Company in all aspects relating to the Proposal. The directors who are representatives of the three main shareholders of the Company are not involved in the Company’s deliberations and decisions. The independent committee is actively engaging in the Proposal in line with applicable regul